Welldoc®, a leading digital health company, announced today that it has secured a technology patent (based on U.S. Patent Application No. 15/923,010) from the United States Patent and Trademark Office for the Software Engine Technology that powers its BlueStar® digital therapeutic.
“The awarding of this tenth technology patent to Welldoc is a validation of our innovation in digital health and our deliberate strategy to create a simple, sustainable and scalable solution for all people living with diabetes,” said Welldoc President and CEO Kevin McRaith. “We are trailblazers who have paved the way for other digital health companies seeking both patent and regulatory approval in the marketplace.”
Welldoc’s groundbreaking technology is guiding individuals through the complex journey of living with chronic disease, with the goal of helping individuals improve how they self-manage their conditions to significantly improve their clinical outcomes and help drive cost savings. The Company’s innovative approach leverages mobile technology, artificial intelligence, the Internet of Things (IoT) devices, and precision algorithms — driven by its patented software engine — to facilitate significant health outcomes. Additionally, its digital therapeutic solutions connect individuals living with diabetes to their own healthcare team for optimal communication and ongoing support.
Click here to read the entire press release.